Clinical Significance of Perihepatic Lymphadenopathy in Patients with Chronic Hepatitis C Infection
- First Online:
- 85 Downloads
Patients with chronic hepatitis C (HCV) infection commonly have perihepatic lymph node enlargement (PLNE). We investigated the prognostic value of PLNE in the development of complicated cirrhosis and death, as well as the clinical and laboratory factors associated with the presence of PLNE in a cohort of HCV-infected veterans.
Using a retrospective cohort design, we compared the rate of development of decompensated cirrhosis and/or death in a group of HCV-infected patients who did not have evidence of decompensated cirrhosis stratified by the presence or absence of PLNE. We used Kaplan–Meier survival curves. We then evaluated which factors were predictive of detection of PLNE using logistic regression.
A total of 131 patients were included in the study. Fifty-nine patients had PLNE and 72 patients did not. After a mean follow-up of 42 months, survival in the absence of progression to decompensated cirrhosis and/or death was not significantly different between the two groups (log-rank test, p = 0.27). The only factor predictive of progression to decompensated cirrhosis and/or death was the presence of cirrhosis at baseline (HR 13.13, 95% CI 2.21–79.41). In addition, cirrhosis was the only factor predictive of the detection of PLNE on CT scan (OR 3.09: CI 2.1–25.9).
Presence of PLNE in patients with chronic HCV infection is strongly associated with subclinical cirrhosis. However, PLNE does not independently predict the progression of liver disease to decompensated cirrhosis and/or death in HCV-infected patients.
KeywordsHepatitis C Cirrhosis Perihepatic lymphadenopathy Prognosis
- 6.Moore KL, Dalley AF, Agur AMR. Clinically oriented anatomy. 5th ed. Philadelphia, PA: Lippincott, Williams, & Wilkins; 2006:298–299.Google Scholar
- 9.Maeda T, Hori Y, Yamaguchi N, et al. Clinical significance of lymphadenopathy in the upper abdomen: ultrasound demonstration. Nippon Acta Radiogica. 1995;55:228–232.Google Scholar
- 16.Dietrich CF, Stryjek-Kaminska D, Teuber G, Lee J, Caspary WF, Zeuzem S. Perihepatic lymph nodes as a marker of antiviral response in patients with chronic hepatitis C infection. Am J Roentgenol. 2000;174:699–704.Google Scholar
- 18.Dofman RE, Alpern MB, Gross BH, Sandler MA. Upper abdominal lymph node: criteria for normal size determined with CT. Radiology. 1991;180:319–322.Google Scholar
- 22.Ferenci P, Laferl H, Scherzer TM, Gschwantler M, Maieron A, Brunner H, et al. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response. Gastroenterology. 2008; 135:451–458. 2008 May 27.Google Scholar
- 27.Choi, PC, Kim HJ, Choi WH, Park D, Park JH, Cho YK, et al. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis. Liver international 2009; 221–226.Google Scholar
- 29.Dod GD, Baron RL, Oliver JH, Federle MP, Baumgartel PB. Enlarged abdominal lymph nodes in end-stage cirrhosis: CT-histopathologic correlation in 507 patients. Radiology. 1997;203:127–130.Google Scholar
- 30.Saadoun D, Asselah T, Resche-Rigon M, Charlotte F, Bedossa P, Valla D, Piette JC, Marcellin P, Cacoub P. Hepatology 2006; 43:1337–1345.Google Scholar